Atlantic Coastal Acquisition Corp. II - Quarter Report: 2022 September (Form 10-Q)
Table of Contents
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware |
85-1013956 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Units, each consisting of one share of Series A common stock, $0.0001 par value, and one-half of one redeemable warrant |
ACABU |
The Nasdaq Stock Market LLC | ||
Shares of Series A common stock included as part of the units |
ACAB |
The Nasdaq Stock Market LLC | ||
Warrants included as part of the units, each whole warrant exercisable for one share of Series A common stock at an exercise price of $11.50 |
ACABW |
The Nasdaq Stock Market LLC |
Large, accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Table of Contents
ATLANTIC COASTAL ACQUISITION CORP. II
FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2022
TABLE OF CONTENTS
Table of Contents
September 30, 2022 |
December 31, 2021 |
|||||||
(Unaudited) |
||||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash |
$ | 189,031 | $ | — | ||||
Prepaid expenses |
489,935 | — | ||||||
|
|
|
|
|||||
Total Current Assets |
678,966 | — | ||||||
Deferred offering costs |
— | 361,372 | ||||||
Marketable securities held in Trust Account |
307,546,474 | — | ||||||
|
|
|
|
|||||
TOTAL ASSETS |
$ | 308,225,440 |
$ |
361,372 |
||||
|
|
|
|
|||||
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY |
||||||||
Current liabilities |
||||||||
Accrued expenses |
$ | 895,709 | $ | 1,793 | ||||
Accrued offering costs |
75,000 | 236,095 | ||||||
Income taxes payable |
293,453 | — | ||||||
Promissory note – related party |
— | 100,277 | ||||||
|
|
|
|
|||||
Total Current Liabilities |
1,264,162 | 338,165 | ||||||
Deferred underwriting fee payable |
10,500,000 | — | ||||||
|
|
|
|
|||||
Total Liabilities |
11,764,162 |
338,165 |
||||||
Commitments (Note 6) |
||||||||
Series A common stock subject to possible redemption; 30,000,000 and no shares issued and outstanding at September 30, 2022 and December 31, 2021 respectively, at redemption value of $10.24 |
307,103,021 | — | ||||||
Stockholders’ (Deficit) Equity |
||||||||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized, none issued and outstanding |
— | — | ||||||
Series A common stock, $0.0001 par value; 100,000,000 shares authorized; none issued and outstanding (excluding 30,000,000 and no shares subject to possible redemption) as of September 30, 2022 and December 31, 2021, respectively |
— | — | ||||||
Series B common stock, $0.0001 par value; 10,000,000 shares authorized; 7,500,000 and 7,503,750 (1) shares issued and outstanding as of September 30, 2022 and December 31, |
750 | 750 | ||||||
Additional paid-in capital |
— | 24,250 | ||||||
Accumulated deficit |
(10,642,493 | ) | (1,793 | ) | ||||
|
|
|
|
|||||
Total Stockholders’ (Deficit) Equity |
(10,641,743 |
) | 23,207 |
|||||
|
|
|
|
|||||
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY |
$ | 308,225,440 |
$ |
361,372 |
||||
|
|
|
|
(1) | Includes up to 978,750 shares of Series B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 7). On January 13, 2022, the Company effectuated a 1.044-for-1 stock per-share amounts have been retroactively restated to reflect the stock split. On January 18, 2022, the underwriters partially exercised their over-allotment option, and hence, 975,000 Founder Shares are no longer subject to forfeiture since such date and the remaining unexercised portion of such over-allotment option, an aggregate of 3,750 Founder Shares, were forfeited, resulting in an aggregate of 7,500,000 Founder Shares outstanding (see Note 7). |
For the Three Months Ended September 30, |
For the Three Months Ended September 30, |
For the Nine Months Ended September 30, |
For the Period from May 20, 2021 (Inception) Through September 30, |
|||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
Operation and formation costs |
$ | 533,796 | $ | 1,000 | $ | 1,461,765 | $ | 1,000 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss from operations |
(533,796 |
) | (1,000 |
) |
(1,461,765 |
) | (1,000 |
) | ||||||||
Other income: |
||||||||||||||||
Interest income – bank |
824 | — | 922 | — | ||||||||||||
Interest earned on marketable securities held in Trust Account |
1,428,511 | — | 1,546,474 | — | ||||||||||||
Unrealized gain on marketable securities held in Trust Account |
43,916 | — | — | — | ||||||||||||
Compensation expense |
— | — | (362,500 | ) | — | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total other income, net |
1,473,251 | — | 1,184,896 | — | ||||||||||||
Income (loss) before provision for income taxes |
939,455 | (1,000 | ) | (276,869 | ) | (1,000 | ) | |||||||||
Provision for income taxes |
(287,034 | ) | — | (293,453 | ) | — | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income (loss) |
$ |
652,421 |
$ |
(1,000 |
) |
$ |
(570,322 |
) |
$ |
(1,000 |
) | |||||
Weighted average shares outstanding, Series A common stock |
30,000,000 | — | 27,912,088 | — | ||||||||||||
Basic and diluted net income (loss) per share, Series A common stock |
$ |
0.02 |
$ |
— |
$ |
(0.02 |
) |
$ |
— |
|||||||
Weighted average shares outstanding, Series B common stock |
7,500,000 | 29,000 | 7,432,143 | 29,000 | ||||||||||||
Basic and diluted net income (loss) per share, Series B common stock |
$ |
0.02 |
$ |
(0.03 |
) |
$ |
(0.02 |
) |
$ |
(0.03 |
) |
Series A Common Stock |
Series B Common Stock |
Additional Paid-in |
Accumulated |
Total Stockholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Equity (Deficit) |
||||||||||||||||||||||
Balance — December 31, 2021 |
— |
$ |
— |
7,503,750 |
$ |
750 |
$ |
24,250 |
$ |
(1,793 |
) |
$ |
23,207 |
|||||||||||||||
Sale of 13,850,000 Private Placement Warrants |
— | — | — | — | 13,850,000 | — | 13,850,000 | |||||||||||||||||||||
Forfeiture of Founder Shares |
— | — | (3,750 | ) | — | — | — | — | ||||||||||||||||||||
Compensation Expense – Fair value of assigned Founder Shares to Apeiron |
— | — | — | — | 362,500 | — | 362,500 | |||||||||||||||||||||
Fair value of Public Warrants at issuance |
— | — | — | — | 8,100,000 | — | 8,100,000 | |||||||||||||||||||||
Allocated value of transaction costs to Series A common stock |
— | — | — | — | (505,049 | ) | — | (505,049 | ) | |||||||||||||||||||
Remeasurement of Series A common stock to redemption amount |
— | — | — | — | (21,831,701 | ) | (8,967,357 | ) | (30,799,058 | ) | ||||||||||||||||||
Net loss |
— | — | — | — | — | (1,025,824 | ) | (1,025,824 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance — March 30, 2022 |
— |
— |
7,500,000 |
750 |
— |
(9,994,974 |
) |
(9,994,224 |
) | |||||||||||||||||||
Net loss |
— | — | — | — | — | (196,919 | ) | (196,919 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance — June 30, 2022 |
— |
— |
7,500,000 |
750 |
— |
(10,191,893 |
) |
(10,191,143 |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Accretion for Series A ordinary shares to redemption amount |
— | — | — | — | — | (1,103,021 | ) | (1,103,021 | ) | |||||||||||||||||||
Net income |
— | — | — | — | — | 652,421 | 652,421 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance — September 30, 2022 |
— |
$ |
— |
7,500,000 |
$ |
750 |
$ |
— |
$ |
(10,642,493 |
) | $ |
(10,641,743 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Common Stock |
Series B Common Stock |
Additional Paid-in |
Accumulated |
Total Stockholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Equity |
||||||||||||||||||||||
Balance — May 20, 2021 (Inception) |
— |
$ |
— |
— |
$ |
— |
$ |
— |
$ |
— |
$ |
— |
||||||||||||||||
Net loss |
— | — | — | — | — | — | — | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance — June 30, 2021 |
— |
— |
— |
— |
— |
— |
— |
|||||||||||||||||||||
Issuance of Class B common stock to Sponsor |
— | — | 7,503,750 | 750 | 24,520 | — | 25,000 | |||||||||||||||||||||
Net loss |
— | — | — | — | — | (1,000 | ) | (1,000 |
) | |||||||||||||||||||
Balance — September 30, 2021 |
— |
$ |
— |
7,503,750 |
$ |
750 |
$ |
24,520 |
$ |
(1,000 |
) |
$ |
24,000 |
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2022 |
For the Period from May 20, 2021 (Inception) Through September 30, 2021 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net loss |
$ | (570,322 | ) | $ | (1,000 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
Interest earned on marketable securities held in Trust Account |
(1,546,474 | ) | — | |||||
Compensation expenses |
362,500 | — | ||||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
(489,935 | ) | — | |||||
Accrued expenses |
893,916 | 1,000 | ||||||
Income taxes payable |
293,453 | — | ||||||
|
|
|
|
|||||
Net cash used in operating activities |
(1,056,862 |
) |
— |
|||||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Investment of cash into Trust Account |
$ | (306,000,000 | ) | $ | — | |||
|
|
|
|
|||||
Net cash used in investing activities |
(306,000,000 |
) |
— |
|||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Proceeds from sale of Units, net of underwriting discounts paid |
$ | 294,240,000 | $ | — | ||||
Proceeds from sale of Private Placement Warrants |
13,850,000 | — | ||||||
Proceeds from promissory note – related party |
49,262 | 30,000 | ||||||
Repayment of promissory note – related party |
(149,539 | ) | — | |||||
Payment of offering costs |
(743,830 | ) | (30,000 | ) | ||||
|
|
|
|
|||||
Net cash provided by financing activities |
307,245,893 |
— |
||||||
|
|
|
|
|||||
Net Change in Cash |
189,031 |
— |
||||||
Cash – Beginning of period |
— | — | ||||||
|
|
|
|
|||||
Cash – End of period |
$ |
189,031 |
$ |
— |
||||
|
|
|
|
|||||
Non-cash investing and financing activities: |
||||||||
Offering costs included in accrued offering costs |
$ | 717,219 | $ | 120,634 | ||||
|
|
|
|
|||||
Initial classification of Series A common stock subject to possible redemption |
$ | 307,103,021 | $ | — | ||||
|
|
|
|
|||||
Offering costs paid by Sponsor in exchange for issuance of founder shares |
$ | — | $ | 25,000 | ||||
|
|
|
|
|||||
Deferred underwriting fee payable |
$ | 10,500,000 | $ | — | ||||
|
|
|
|
Gross proceeds |
$ | 300,000,000 | ||
Less: |
||||
Proceeds allocated to Public Warrants |
(8,100,000 | ) | ||
Series A common stock issuance costs |
(16,699,058 | ) | ||
Plus: |
||||
Remeasurement of carrying value to redemption value |
31,902,079 | |||
|
|
|||
Series A common stock subject to possible redemption |
$ |
307,103,021 |
||
|
|
Three Months Ended September 30, 2022 |
Three Months Ended September 30, 2021 |
Nine Months Ended September 30, 2022 |
For the Period from May 20, 2021 (Inception) Through September 30, 2021 |
|||||||||||||||||||||||||||||
Series A |
Series B |
Series A |
Series B |
Series A |
Series B |
Series A |
Series B |
|||||||||||||||||||||||||
Basic and diluted net per common stock |
||||||||||||||||||||||||||||||||
Numerator: |
||||||||||||||||||||||||||||||||
Allocation of net income (loss), as adjusted |
$ | 521,937 | $ | 130,484 | $ | — | $ | (1,000 | ) | $ | (450,395 | ) | $ | (119,927 | ) | $ | — | $ | (1,000 | ) | ||||||||||||
Denominator: |
||||||||||||||||||||||||||||||||
Basic and diluted weighted average shares outstanding |
30,000,000 | 7,500,000 | — | 29,000 | 27,912,088 | 7,432,143 | — | 29,000 | ||||||||||||||||||||||||
Basic and diluted net income (loss) per common stock |
$ | 0.02 | $ | 0.02 | $ | — | (0.03 | ) | $ | (0.02 | ) | $ | (0.02 | ) | $ | — | $ | (0.03 | ) |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon not less than 30 days’ prior written notice of redemption given after the warrants become exercisable to each warrant holder; and |
• | if, and only if, the reported last sale price of the Series A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a period commencing once the warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders. |
Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. | |
Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. | |
Level 3: | Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
September 30, 2022 |
||||||||
Level |
Amount |
|||||||
Assets: |
||||||||
Marketable securities held in Trust Account |
1 | $ | 307,546,474 |
Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Atlantic Coastal Acquisition Corp. II. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Atlantic Coastal Acquisition Management II LLC. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes thereto included elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Proposed Business Combination (as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that the conditions of the Proposed Business Combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its Initial Public Offering filed with the U.S. Securities and Exchange Commission (the “SEC”) and the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the SEC. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company incorporated in Delaware on May 20, 2021 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. We may pursue an initial business combination target in any industry or sector, but given the experience of our management team, we expect to focus on acquiring a business combination target within the financial services industry and related sectors, including potentially the mobility sector. We intend to effectuate our Business Combination using cash from the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, our capital stock, debt or a combination of cash, stock and debt.
We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities from May 20, 2021 (inception) through September 30, 2022 were organizational activities, those necessary to consummate the Initial Public Offering, described below, and identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended September 30, 2022, we had a net income of $652,421 which consists of interest income from bank of $824 and an unrealized gain on marketable securities held in our Trust Account of $43,916 and interest earned marketable securities held in the Trust Account of $1,428,511, offset by operating and formation costs of $533,796 and provision for income taxes of $287,034.
For the nine months ended September 30, 2022, we had a net loss of $570,322 which consists of operating and formation costs of $1,461,765, compensation expenses of $362,500 and provision for income taxes of $293,453, offset by interest income from bank of $922 and interest earned on marketable securities held in the Trust Account of $1,546,474.
For the three months ended September 30, 2021, we had a net loss of $1,000.
For the period from May 20, 2021 (Inception) through September 30, 2021, we had a net loss of $1,000.
Liquidity and Capital Resources
On January 19, 2022, we consummated our Initial Public Offering of 30,000,000 Units, which includes the partial exercise by the underwriters of its over-allotment option in the amount of 3,900,000 Units at $10.00 per Unit, generating gross proceeds of $300,000,000. Simultaneously with the closing of our Initial Public Offering, we consummated the sale of 13,850,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds of $13,850,000.
Transaction costs amounted to $17,204,107 consisting of $5,760,000 of underwriting discount (net of $240,000 reimbursed by the underwriters) and $944,107 of other offering costs. We have agreed to pay a deferred underwriting fee to the underwriters upon the consummation of our Initial Business Combination in an amount equal to, in the aggregate, 3.5% of the gross proceeds of the Initial Public Offering or an aggregate of $10,500,000.
The promissory note issued in connection with unsecured loans from our Sponsor to finance our liquidity needs through the consummation of our Initial Public Offering was non-interest bearing and the aggregate amount of $149,539 outstanding under the promissory note as of January 19, 2022 was fully repaid on February 22, 2022.
17
Table of Contents
Following the Initial Public Offering, the partial exercise of the over-allotment option, and the sale of Private Placement Warrants, a total of $306,000,000 was placed in the Trust Account. We incurred $17,204,107 in Initial Public Offering related costs, including $5,760,000 of underwriting fees and $944,107 of other costs.
For the nine months ended September 30, 2022, cash used in operating activities was $1,056,862. Net loss of $570,322 was affected by interest earned on marketable securities held in the Trust Account of $1,546,474 and compensation expenses of $362,500. Changes in operating assets and liabilities used $697,434 of cash for operating activities.
For the period from May 20, 2021 (Inception) through September 30, 2021, net loss of $1,000 was affected by the changes in operating assets and liabilities of $1,000.
As of September 30, 2022, we had marketable securities held in the Trust Account of $307,546,474 consisting of U.S. Treasury Bills with a maturity of 185 days or less. Interest income on the balance in the Trust Account may be used by us to pay taxes. Through September 30, 2022, we have not withdrawn any interest earned from the Trust Account.
We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of September 30, 2022, we had cash of $189,031. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor has committed to provide us $1,750,000 to fund our expenses relating to investigating and selecting a target business and other working capital requirements. In addition, our Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us additional funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants.
We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. If we are unable to complete our Initial Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account.
Going Concern
Until the consummation of a Business Combination, we will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.
In connection with the Company’s assessment of going concern considerations in accordance with ASC Topic 205-40,“Presentation of Financial Statements—Going Concern,” the Company has until April 19, 2023, to consummate a Business Combination. If a Business Combination is not consummated by this date and an extension not requested by the Sponsor, there will be a mandatory liquidation and subsequent dissolution of the Company. Although the Company intends to consummate a Business Combination on or before April 19, 2023, it is uncertain that the Company will be able to consummate a Business Combination by this time. Management has determined that the liquidity condition, coupled with the mandatory liquidation, should a Business Combination not occur and an extension is not requested by the Sponsor, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. The Company’s plan is to complete a business combination or obtain an extension on or prior to April 19, 2023; however it is uncertain that the Company will be able to consummate a Business Combination or obtain an extension by this time. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after April 19, 2023.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2022. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
Contractual obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than the following:
The underwriters were entitled to a cash underwriting discount of $0.20 per Unit, or $6,000,000 in the aggregate, paid on the closing of the Initial Public Offering. In addition, the underwriters are entitled to a deferred fee of $0.35 per Unit, or $10,500,000 in the aggregate. The deferred fee will become payable to the underwriter from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.
18
Table of Contents
Critical Accounting Policies
The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:
Deferred Offering Costs
We comply with the requirements of the ASC 340-10-S99-1 and SEC SAB Topic 5A – “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Initial Public Offering. Offering costs are allocated based on the relative value of the Public and Private Warrants to the proceeds received from the Public Shares sold in the Initial Public Offering. Offering costs allocated to the Public Shares are charged to temporary equity and offering costs allocated to the Public and Private Warrants are charged to stockholder’s equity. As of January 19, 2022, offering costs in the aggregate of $17,204,107, of which an aggregate of $16,699,058 have been charged to temporary equity and an aggregate of $505,049 have been charged to stockholders’ equity.
As of September 30, 2022 and December 31, 2021, there were $0 and $361,372 of deferred offering costs recorded in the accompanying condensed balance sheets, respectively.
Common Stock Subject to Possible Redemption
We account for our common stock subject to possible conversion in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as a component of stockholders’ equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity outside of the stockholders’ equity section of our condensed balance sheets.
Warrants
We account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC 815, “Derivatives and Hedging”. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to our own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period date while the warrants are outstanding. Based on our assessment of the guidance, our warrants meet the criteria for equity classification and are recorded within stockholders’ equity.
Net Loss Per Common Share
Net loss per common stock is computed by dividing net loss by the weighted average number of common stock outstanding for the period. Accretion associated with the redeemable shares of Series A common stock is excluded from earnings per share as the redemption value approximates fair value.
Recent Accounting Standards
In August 2020, the FASB issued ASU No. 2020-06,“Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. We are currently assessing the impact, if any, that ASU 2020-06 would have on our financial position, results of operations or cash flows.
Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Not required for smaller reporting companies.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
19
Table of Contents
Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2022, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial and accounting officer have concluded that during the period covered by this report, our disclosure controls and procedures were effective at a reasonable assurance level and, accordingly, provided reasonable assurance that the information required to be disclosed by us in reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.
We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the fiscal quarter of 2022 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II—OTHER INFORMATION
Item 1. Legal Proceedings
None
Item 1A. Risk Factors
There are no material changes to the risk factors in our most recent Annual Report on Form 10-K as filed with the SEC on March 25, 2022.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
On October 25, 2021, we issued 7,187,500 shares of our Series B common stock, to our Sponsor for $25,000 in cash, at a purchase price of approximately $0.035 per share (or $0.0033 per share, after giving effect to a 1.044-for-1 stock split on January 13, 2022), in connection with our formation. Such shares were issued in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. On January 13, 2022, we effectuated a 1.044-for-1 stock split, resulting in an aggregate of 7,503,750 Founder Shares outstanding and held by our Initial Stockholders. On January 18, 2022, the underwriters partially exercised their over-allotment option and the remaining unexercised portion of over-allotment option were forfeited, an aggregate of 3,750 Founder Shares were forfeited, resulting in an aggregate of 7,500,000 Founder Shares outstanding held by our Initial Stockholders.
On January 13, 2022, we consummated the Initial Public Offering of 30,000,000 Units. Each Unit consists of one share of Series A common stock and one-half of a redeemable warrant, each warrant entitling the holder thereof to purchase one share of Series A common stock for $11.50 per share. The Units were sold at an offering price of $10.00 per unit, generating total gross proceeds of $300,000,000. Cantor Fitzgerald & Co. acted as sole book-running manager. The securities sold in the Initial Public Offering were registered under the Securities Act on a Registration Statement on Form S-1 (No. 333-261459), which was declared effective by the SEC on January 13, 2022.
Simultaneously with the closing of our Initial Public Offering, we consummated a Private Placement of 13,850,000 private placement warrants, at a price of $1.00 per Private Placement Warrant, to our Sponsor, generating gross proceeds of $13,850,000. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
Following the closing of our Initial Public Offering and the sale of the Private Placement Warrants, an aggregate amount of $306,000,000 ($10.20 per unit) was placed in a Trust Account.
Transaction costs amounted to $17,204,107, consisting of $5,760,000 in underwriting discount (net of $240,000 reimbursed by the underwriters), $10,500,000 in deferred underwriting discount and $944,107 of other offering costs. In addition, $1,819,051 of cash is held outside of the Trust Account and is available for the payment of offering costs and for working capital purposes as of the Initial Public Offering date.
For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
20
Table of Contents
Item 5. Other Information
None.
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
* | Filed herewith. |
21
Table of Contents
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ATLANTIC COASTAL ACQUISITION CORP. II | ||||||
Date: November 10, 2022 | By: | /s/ Shahraab Ahmad | ||||
Name: | Shahraab Ahmad | |||||
Title: | Chief Executive Officer | |||||
(Principal Executive Officer) | ||||||
Date: November 10, 2022 | By: | /s/ Jason Chryssicas | ||||
Name: | Jason Chryssicas | |||||
Title: | Chief Financial Officer | |||||
(Principal Financial and Accounting Officer) |
22